back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-03 15:39 Tx date 2022-05-30 |
$TBP
Tetra Bio-Pharma Inc. |
Auld, Leslie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-03 15:38 Tx date 2022-05-30 |
$TBP
Tetra Bio-Pharma Inc. |
Auld, Leslie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-22 11:54 Tx date 2021-12-21 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$68,250
+350,000 vol $0.195 each |
425,000 | |
| Filed 2021-12-22 11:52 Tx date 2021-12-21 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$57,050
+350,000 vol $0.163 each |
496,000 | |
| Filed 2021-06-03 17:43 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-03 17:41 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-02 14:45 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
46 - Compensation for services
|
$49,999
+140,845 vol $0.355 each |
404,002 | |
| Filed 2021-06-02 12:58 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-02 12:55 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-01 23:31 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 23:24 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 20:04 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 20:04 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:02 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 19:53 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-28 20:18 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2021-05-28 20:16 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
146,000 | ||
| Filed 2021-05-03 10:28 Tx date 2021-05-03 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,100
-50,000 vol $0.482 each |
82,960 | |
| Filed 2021-04-30 09:50 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$6,093
+17,410 vol $0.35 each |
17,410 | |
| Filed 2021-04-30 09:49 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-30 09:47 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-5,999
-17,140 vol $0.35 each |
132,960 | |
| Filed 2021-04-30 09:44 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,800
+80,000 vol $0.21 each |
150,100 | |
| Filed 2021-04-30 09:42 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,800
-80,000 vol $0.21 each |
0 | |
| Filed 2021-03-16 14:46 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
MERTON, Carl
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+263,157 vol |
263,157 | |
| Filed 2021-03-16 14:37 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
MERTON, Carl
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-16 14:28 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-16 14:26 Tx date 2020-09-15 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-16 14:25 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
defered share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-16 13:05 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-16 13:03 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-16 13:02 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-15 17:39 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-12 12:56 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
defered share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-15 21:35 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-49,999.83
-263,157 vol $0.19 each |
||
| Filed 2021-03-15 21:35 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-15 17:47 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-49,999.83
-263,157 vol $0.19 each |
||
| Filed 2021-03-15 17:47 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-49,999.83
-263,157 vol $0.19 each |
1,832,457 | |
| Filed 2021-03-15 17:44 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,999
+263,157 vol $0.19 each |
||
| Filed 2021-03-15 17:44 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,999
+263,157 vol $0.19 each |
2,095,614 | |
| Filed 2021-03-15 17:39 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
1,832,457 | |
| Filed 2021-03-15 12:15 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-15 12:10 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 12:56 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
defered share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-12 12:53 Tx date 2020-09-15 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
defered share unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 12:04 Tx date 2020-06-24 |
$TBP
Tetra Bio-Pharma Inc. |
MacLean, Christopher John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$12,600
+60,000 vol $0.21 each |
60,000 | |
| Filed 2020-07-03 11:58 Tx date 2019-05-01 |
$TBP
Tetra Bio-Pharma Inc. |
MacLean, Christopher John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 10:33 Tx date 2020-06-24 |
$TBP
Tetra Bio-Pharma Inc. |
Kelly, Melanie Edna Mary
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+100,000 vol $0.21 each |
100,000 | |
| Filed 2020-07-03 10:28 Tx date 2019-05-01 |
$TBP
Tetra Bio-Pharma Inc. |
Kelly, Melanie Edna Mary
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-30 13:38 Tx date 2020-06-25 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,800
+80,000 vol $0.21 each |
80,000 | |
| Filed 2020-06-30 11:29 Tx date 2020-06-30 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$16,800
+80,000 vol $0.21 each |
||
| Filed 2020-06-30 11:29 Tx date 2020-06-30 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$16,800
+80,000 vol $0.21 each |
80,000 | |
| Filed 2020-06-30 11:16 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-30 09:57 Tx date 2020-06-29 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,425
+95,000 vol $0.215 each |
4,815,436 | |
| Filed 2020-06-29 09:05 Tx date 2020-06-24 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,150
+115,000 vol $0.21 each |
465,000 | |
| Filed 2020-05-22 14:42 Tx date 2020-05-22 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,800
+20,000 vol $0.24 each |
1,569,300 | |
| Filed 2020-02-18 11:28 Tx date 2020-02-13 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+142,000 vol |
142,000 | |
| Filed 2020-02-18 11:26 Tx date 2020-02-13 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$75,260
+142,000 vol $0.53 each |
311,000 | |
| Filed 2020-02-18 10:34 Tx date 2018-12-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-200,000
-4,000,000 vol $0.05 each |
0 | |
| Filed 2020-02-18 10:33 Tx date 2017-06-07 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$100,000
+2,000,000 vol $0.05 each |
4,000,000 | |
| Filed 2018-12-09 14:39 Tx date 2018-12-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-200,000
-4,000,000 vol $0.05 each |
||
| Filed 2017-06-12 17:23 Tx date 2017-06-07 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$100,000
+2,000,000 vol $0.05 each |
||
| Filed 2020-02-13 16:34 Tx date 2020-02-13 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$141,750
+189,000 vol $0.75 each |
311,700 | |
| Filed 2020-02-13 16:33 Tx date 2020-02-13 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,170
+189,000 vol $0.53 each |
461,700 | |
| Filed 2020-01-24 11:49 Tx date 2020-01-22 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$33,600
+84,000 vol $0.40 each |
169,000 | |
| Filed 2020-01-24 11:46 Tx date 2020-01-22 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-33,600
-84,000 vol $0.40 each |
0 | |
| Filed 2020-01-24 11:34 Tx date 2020-01-22 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$33,600
+84,000 vol $0.40 each |
||
| Filed 2019-11-11 14:01 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 11:13 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-06 17:29 Tx date 2019-11-06 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,435
+7,000 vol $0.205 each |
1,549,300 | |
| Filed 2019-10-11 14:14 Tx date 2019-05-01 |
$TBP
Tetra Bio-Pharma Inc. |
Kelly, Melanie Edna Mary
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,707,288 | ||
| Filed 2019-09-23 17:15 Tx date 2019-05-01 |
$TBP
Tetra Bio-Pharma Inc. |
MacLean, Christopher John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
661,847 | ||
| Filed 2019-08-13 14:01 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Giguere, Richard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
| Filed 2019-08-13 14:00 Tx date 2018-06-19 |
$TBP
Tetra Bio-Pharma Inc. |
Giguere, Richard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-13 14:00 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Giguere, Richard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$7,500
+25,000 vol $0.30 each |
25,000 | |
| Filed 2019-08-13 13:59 Tx date 2018-06-19 |
$TBP
Tetra Bio-Pharma Inc. |
Giguere, Richard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-06 12:13 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
50,000 | |
| Filed 2019-08-06 12:12 Tx date 2018-04-10 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-06 12:11 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+50,000 vol $0.30 each |
546,385 | |
| Filed 2019-08-06 12:10 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+83,400 vol |
83,400 | |
| Filed 2019-08-06 12:07 Tx date 2019-05-15 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-06 12:05 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,020
+83,400 vol $0.30 each |
83,400 | |
| Filed 2019-08-06 11:57 Tx date 2019-05-15 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-05 12:25 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$6,810
+22,700 vol $0.30 each |
272,700 | |
| Filed 2019-08-05 12:24 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+22,700 vol |
122,700 | |
| Filed 2019-08-02 14:01 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+84,000 vol |
84,000 | |
| Filed 2019-08-02 13:59 Tx date 2016-04-01 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 13:55 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,200
+84,000 vol $0.30 each |
85,000 | |
| Filed 2019-08-02 12:52 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,720
+66,800 vol $0.40 each |
66,800 | |
| Filed 2019-08-02 12:43 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 12:34 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,040
+66,800 vol $0.30 each |
1,542,300 | |
| Filed 2019-08-02 12:30 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$26,720
+66,800 vol $0.40 each |
66,800 | |
| Filed 2019-08-02 12:27 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 12:15 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,040
+66,800 vol $0.30 each |
141,800 | |
| Filed 2019-08-02 11:39 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2019-08-02 11:36 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 11:13 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2019-08-02 11:00 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+50,000 vol $0.30 each |
70,100 | |
| Filed 2019-07-19 16:44 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$40,000
+100,000 vol $0.40 each |
100,000 | |
| Filed 2019-07-19 16:42 Tx date 2019-05-14 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-19 16:38 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,000
+100,000 vol $0.30 each |
250,000 | |
| Filed 2019-07-19 16:33 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,000
+100,000 vol $0.30 each |
||
| Filed 2019-07-19 16:33 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$40,000
+100,000 vol $0.40 each |
||
| Filed 2019-07-16 08:35 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$40,000
+100,000 vol $0.40 each |
||
| Filed 2019-07-16 08:34 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,000
+100,000 vol $0.30 each |
||
| Filed 2019-07-16 08:35 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$40,000
+100,000 vol $0.40 each |
100,000 | |
| Filed 2019-07-16 08:34 Tx date 2019-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,000
+100,000 vol $0.30 each |
300,000 | |
| Filed 2019-05-21 12:26 Tx date 2019-05-17 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+3,065 vol $0.62 each |
1,475,500 | |
| Filed 2019-05-16 14:06 Tx date 2019-05-01 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+496,385 vol |
496,385 | |
| Filed 2019-05-16 13:47 Tx date 2018-04-10 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-16 13:46 Tx date 2018-04-10 |
$TBP
Tetra Bio-Pharma Inc. |
Drohan, Gregory John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2019-05-15 07:35 Tx date 2019-05-14 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2019-05-10 13:39 Tx date 2019-05-09 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$806,988
+1,461,935 vol $0.55 each |
1,472,435 | |
| Filed 2019-03-06 Tx date 2019-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
500,000 | |
| Filed 2019-03-06 Tx date 2018-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
||
| Filed 2019-02-15 Tx date 2018-02-08 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$206,999
+300,000 vol $0.69 each |
500,000 | |
| Filed 2019-02-07 Tx date 2019-02-07 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,070
+6,500 vol $0.78 each |
10,500 | |
| Filed 2019-02-07 Tx date 2019-02-07 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,112
+12,800 vol $0.79 each |
20,100 | |
| Filed 2019-02-07 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,300 | ||
| Filed 2019-02-07 Tx date 2019-02-07 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,800
+20,000 vol $0.79 each |
75,000 | |
| Filed 2019-01-02 Tx date 2018-12-27 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,840
+4,000 vol $0.71 each |
4,000 | |
| Filed 2018-12-20 Tx date 2018-12-19 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,350
+35,000 vol $0.81 each |
55,000 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$TBP
Tetra Bio-Pharma Inc. |
Aphria Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,500,000
+10,000,000 vol $0.95 each |
26,900,000 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-4,750,000
-5,000,000 vol $0.95 each |
4,720,436 | |
| Filed 2018-12-10 Tx date 2016-04-01 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-10 Tx date 2018-12-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$920.00
+1,000 vol $0.92 each |
1,000 | |
| Filed 2018-12-09 Tx date 2018-12-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-200,000
-4,000,000 vol $0.05 each |
0 | |
| Filed 2018-12-09 Tx date 2018-12-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,000,000 vol |
9,720,436 | |
| Filed 2018-12-04 Tx date 2018-11-30 |
$TBP
Tetra Bio-Pharma Inc. |
Aphria Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000,000 | ||
| Filed 2018-12-04 Tx date 2018-11-30 |
$TBP
Tetra Bio-Pharma Inc. |
Aphria Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+6,900,000 vol |
6,900,000 | |
| Filed 2018-12-04 Tx date 2018-11-30 |
$TBP
Tetra Bio-Pharma Inc. |
Aphria Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-04 Tx date 2018-11-30 |
$TBP
Tetra Bio-Pharma Inc. |
Aphria Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,107,000
+6,900,000 vol $1.03 each |
16,900,000 | |
| Filed 2018-09-06 Tx date 2018-08-31 |
$TBP
Tetra Bio-Pharma Inc. |
Courchesne, Denis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,010
+9,100 vol $1.10 each |
16,100 | |
| Filed 2018-07-03 Tx date 2018-06-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+50,000 vol $0.25 each |
||
| Filed 2018-07-03 Tx date 2018-06-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+50,000 vol $0.25 each |
||
| Filed 2018-03-19 Tx date 2018-03-19 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
45 - Compensation for property
|
+4,970,436 vol |
6,585,436 | |
| Filed 2018-03-19 Tx date 2018-03-19 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
45 - Compensation for property
|
+4,970,436 vol |
5,720,436 | |
| Filed 2018-03-14 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2018-03-14 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-14 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
CHELIAK, WILLIAM
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-10 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
MERTON, Carl
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-10 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
MERTON, Carl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$284,000
+400,000 vol $0.71 each |
400,000 | |
| Filed 2018-03-09 Tx date 2018-03-02 |
$TBP
Tetra Bio-Pharma Inc. |
Chotard, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2018-03-09 Tx date 2018-03-02 |
$TBP
Tetra Bio-Pharma Inc. |
Chotard, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,400,000 | ||
| Filed 2018-02-09 Tx date 2017-08-23 |
$TBP
Tetra Bio-Pharma Inc. |
Courtois, Anne-Sophie Marie Claude
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2018-02-09 Tx date 2017-08-23 |
$TBP
Tetra Bio-Pharma Inc. |
Courtois, Anne-Sophie Marie Claude
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-09 Tx date 2017-11-30 |
$TBP
Tetra Bio-Pharma Inc. |
Courtois, Anne-Sophie Marie Claude
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
275,000 | |
| Filed 2018-01-31 Tx date 2018-01-26 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$62,500
+1,250,000 vol $0.05 each |
1,615,000 | |
| Filed 2018-01-31 Tx date 2018-01-26 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-62,500
-1,250,000 vol $0.05 each |
150,000 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,486.20
-12,900 vol $1.28 each |
750,000 | |
| Filed 2018-01-12 Tx date 2018-01-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,207
-15,300 vol $1.19 each |
1,022,500 | |
| Filed 2018-01-12 Tx date 2018-01-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,775
-22,500 vol $1.19 each |
1,000,000 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,367
-46,200 vol $1.28 each |
953,800 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,760
-4,500 vol $1.28 each |
949,300 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-183,300
-141,000 vol $1.30 each |
808,300 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,292
-13,200 vol $1.31 each |
795,100 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,488
-24,600 vol $1.28 each |
770,500 | |
| Filed 2018-01-12 Tx date 2018-01-10 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,690
-7,600 vol $1.27 each |
762,900 | |
| Filed 2018-01-12 Tx date 2018-01-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,000
-67,500 vol $1.20 each |
1,182,500 | |
| Filed 2018-01-12 Tx date 2018-01-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-155,160
-129,300 vol $1.20 each |
1,053,200 | |
| Filed 2018-01-12 Tx date 2018-01-05 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,403
-15,400 vol $1.20 each |
1,037,800 | |
| Filed 2018-01-08 Tx date 2018-01-02 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,650
-15,000 vol $1.31 each |
365,000 | |
| Filed 2018-01-03 Tx date 2018-01-03 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$100,000
+2,000,000 vol $0.05 each |
4,000,000 | |
| Filed 2018-01-03 Tx date 2016-09-19 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-03 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$142,000
+200,000 vol $0.71 each |
200,000 | |
| Filed 2017-12-08 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
350,000 | |
| Filed 2017-12-04 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2017-12-04 Tx date 2017-12-04 |
$TBP
Tetra Bio-Pharma Inc. |
Courchesne, Denis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$142,000
+200,000 vol $0.71 each |
200,000 | |
| Filed 2017-12-04 Tx date 2017-05-04 |
$TBP
Tetra Bio-Pharma Inc. |
Courchesne, Denis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-01 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
Lessard, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
275,000 | |
| Filed 2017-12-01 Tx date 2017-09-18 |
$TBP
Tetra Bio-Pharma Inc. |
Lessard, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-30 Tx date 2017-11-27 |
$TBP
Tetra Bio-Pharma Inc. |
Fortier, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$568,000
+800,000 vol $0.71 each |
1,200,000 | |
| Filed 2017-09-15 Tx date 2017-09-15 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,450
+15,000 vol $0.63 each |
7,018,784 | |
| Filed 2017-09-15 Tx date 2017-09-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,050
-15,000 vol $0.67 each |
7,003,784 | |
| Filed 2017-09-15 Tx date 2017-09-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,600
-10,000 vol $0.66 each |
7,018,784 | |
| Filed 2017-09-15 Tx date 2017-09-15 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+20,000 vol $0.63 each |
7,038,784 | |
| Filed 2017-09-11 Tx date 2017-09-07 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,800
-10,000 vol $0.68 each |
7,028,784 | |
| Filed 2017-09-08 Tx date 2017-09-06 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,700
-10,000 vol $0.67 each |
7,038,784 | |
| Filed 2017-09-08 Tx date 2017-09-05 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,380
-2,000 vol $0.69 each |
7,058,784 | |
| Filed 2017-09-08 Tx date 2017-09-06 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,800
-10,000 vol $0.68 each |
7,048,784 | |
| Filed 2017-09-06 Tx date 2017-09-01 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-10,000 vol $0.70 each |
7,060,784 | |
| Filed 2017-09-01 Tx date 2017-08-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,650
-15,000 vol $0.71 each |
7,135,784 | |
| Filed 2017-09-01 Tx date 2017-08-30 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,650
-15,000 vol $0.71 each |
7,090,784 | |
| Filed 2017-09-01 Tx date 2017-08-29 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,840
-4,000 vol $0.71 each |
7,105,784 | |
| Filed 2017-09-01 Tx date 2017-08-29 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,380
-6,000 vol $0.73 each |
7,109,784 | |
| Filed 2017-09-01 Tx date 2017-08-31 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,000
-20,000 vol $0.70 each |
7,070,784 | |
| Filed 2017-09-01 Tx date 2017-08-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-10,000 vol $0.73 each |
7,115,784 | |
| Filed 2017-09-01 Tx date 2017-08-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,200
-10,000 vol $0.72 each |
7,125,784 | |
| Filed 2017-08-28 Tx date 2017-08-24 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,650
-15,000 vol $0.71 each |
7,150,784 | |
| Filed 2017-08-24 Tx date 2017-08-23 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,095
-1,500 vol $0.73 each |
7,165,784 | |
| Filed 2017-08-24 Tx date 2017-08-23 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,100
-10,000 vol $0.71 each |
7,167,284 | |
| Filed 2017-08-23 Tx date 2017-08-18 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,550
-15,000 vol $0.77 each |
7,177,284 | |
| Filed 2017-08-21 Tx date 2017-08-17 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,400
-15,000 vol $0.76 each |
7,192,284 | |
| Filed 2017-08-18 Tx date 2017-08-16 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,400
-8,000 vol $0.80 each |
7,207,284 | |
| Filed 2017-08-16 Tx date 2017-08-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,330
-4,500 vol $0.74 each |
7,215,284 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$26,600
+380,000 vol $0.07 each |
6,725,784 | |
| Filed 2017-08-11 Tx date 2017-08-09 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,440
-6,000 vol $0.74 each |
7,219,784 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-35,000
-500,000 vol $0.07 each |
0 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-26,600
-380,000 vol $0.07 each |
500,000 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$35,000
+500,000 vol $0.07 each |
7,225,784 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,950
-15,000 vol $0.73 each |
6,345,784 | |
| Filed 2017-08-11 Tx date 2017-08-08 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,810
-6,500 vol $0.74 each |
6,360,784 | |
| Filed 2017-08-10 Tx date 2017-08-10 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,100
+10,000 vol $0.71 each |
117,500 | |
| Filed 2017-08-08 Tx date 2017-08-04 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-10,000 vol $0.73 each |
6,367,284 | |
| Filed 2017-08-08 Tx date 2017-08-04 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,100
-15,000 vol $0.74 each |
6,377,284 | |
| Filed 2017-08-08 Tx date 2017-08-03 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,250
-3,000 vol $0.75 each |
6,392,284 | |
| Filed 2017-08-04 Tx date 2017-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,800
-20,000 vol $0.74 each |
6,395,284 | |
| Filed 2017-08-04 Tx date 2017-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,855
-13,500 vol $0.73 each |
6,415,284 | |
| Filed 2017-08-04 Tx date 2017-08-01 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,875
-10,500 vol $0.75 each |
6,428,784 | |
| Filed 2017-08-04 Tx date 2017-08-01 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,400
-10,000 vol $0.74 each |
6,439,284 | |
| Filed 2017-08-02 Tx date 2017-07-27 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+20,000 vol $0.75 each |
20,000 | |
| Filed 2017-08-02 Tx date 2017-05-10 |
$TBP
Tetra Bio-Pharma Inc. |
Bechard, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-31 Tx date 2017-07-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,140
-1,500 vol $0.76 each |
6,449,284 | |
| Filed 2017-07-31 Tx date 2017-07-26 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,170
-1,500 vol $0.78 each |
6,450,784 | |
| Filed 2017-07-28 Tx date 2017-07-24 |
$TBP
Tetra Bio-Pharma Inc. |
Fortier, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2017-07-27 Tx date 2017-07-27 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,825
+2,500 vol $0.73 each |
107,500 | |
| Filed 2017-07-27 Tx date 2017-07-27 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,700
+5,000 vol $0.74 each |
105,000 | |
| Filed 2017-07-26 Tx date 2017-07-21 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,450
-15,000 vol $0.83 each |
6,452,284 | |
| Filed 2017-07-24 Tx date 2017-07-20 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-10,000 vol $0.81 each |
6,482,284 | |
| Filed 2017-07-24 Tx date 2017-07-20 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,000
-15,000 vol $0.80 each |
6,467,284 | |
| Filed 2017-07-21 Tx date 2017-07-19 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,000
-15,000 vol $0.80 each |
6,492,284 | |
| Filed 2017-07-21 Tx date 2017-07-18 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,000
-10,000 vol $0.80 each |
6,507,284 | |
| Filed 2017-07-21 Tx date 2017-07-18 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,300
-15,000 vol $0.82 each |
6,517,284 | |
| Filed 2017-07-18 Tx date 2017-07-14 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,550
-15,000 vol $0.77 each |
6,532,284 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,000
-10,000 vol $0.80 each |
6,547,284 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,900
-10,000 vol $0.79 each |
6,557,284 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,700
-10,000 vol $0.77 each |
6,567,284 | |
| Filed 2017-07-14 Tx date 2017-07-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-10,000 vol $0.73 each |
6,577,284 | |
| Filed 2017-07-14 Tx date 2017-07-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,400
-10,000 vol $0.74 each |
6,587,284 | |
| Filed 2017-07-14 Tx date 2017-07-11 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,400
-10,000 vol $0.74 each |
6,597,284 | |
| Filed 2017-07-14 Tx date 2017-07-10 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,300
-10,000 vol $0.73 each |
6,607,284 | |
| Filed 2017-07-11 Tx date 2017-07-07 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-10,000 vol $0.75 each |
6,617,284 | |
| Filed 2017-07-11 Tx date 2017-07-06 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,200
-10,000 vol $0.82 each |
6,627,284 | |
| Filed 2017-07-07 Tx date 2017-07-04 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,300
-10,000 vol $0.83 each |
6,637,284 | |
| Filed 2017-06-30 Tx date 2017-06-29 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,600
-15,000 vol $0.84 each |
6,647,284 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,680
-2,000 vol $0.84 each |
6,662,284 | |
| Filed 2017-06-27 Tx date 2017-06-27 |
$TBP
Tetra Bio-Pharma Inc. |
Chotard, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-400,000 vol |
150,000 | |
| Filed 2017-06-27 Tx date 2017-06-27 |
$TBP
Tetra Bio-Pharma Inc. |
Chotard, Benoit
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$72,000
+400,000 vol $0.18 each |
1,400,000 | |
| Filed 2017-06-26 Tx date 2017-06-20 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,650
-15,000 vol $0.91 each |
6,664,284 | |
| Filed 2017-06-26 Tx date 2017-06-19 |
$TBP
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,400
-20,000 vol $0.92 each |
6,679,284 | |
| Filed 2017-06-12 Tx date 2017-06-07 |
$TBP
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Holder: 9315-4466 quebec inc (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$100,000
+2,000,000 vol $0.05 each |
4,000,000 | |
| Filed 2017-06-06 Tx date 2017-06-01 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,250
-25,000 vol $1.01 each |
380,000 | |
| Filed 2017-05-25 Tx date 2017-05-24 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,000
-40,000 vol $0.95 each |
405,000 | |
| Filed 2017-05-25 Tx date 2017-05-24 |
$TBP
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,700
-150,000 vol $0.92 each |
200,000 | |
| Filed 2017-05-24 Tx date 2017-05-23 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-20,000 vol $0.80 each |
445,000 | |
| Filed 2017-05-24 Tx date 2017-05-18 |
$TBP
Tetra Bio-Pharma Inc. |
Courchesne, Denis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,900
+7,000 vol $0.70 each |
7,000 | |
| Filed 2017-05-24 Tx date 2017-05-04 |
$TBP
Tetra Bio-Pharma Inc. |
Courchesne, Denis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-18 Tx date 2017-04-18 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,100
+10,000 vol $0.61 each |
100,000 | |
| Filed 2017-04-17 Tx date 2017-04-17 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+10,000 vol $0.63 each |
90,000 | |
| Filed 2017-04-17 Tx date 2017-04-17 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+10,000 vol $0.63 each |
80,000 | |
| Filed 2017-04-13 Tx date 2017-04-13 |
$TBP
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,350
+5,000 vol $0.67 each |
465,000 | |
| Filed 2017-04-13 Tx date 2017-04-13 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,925
+4,500 vol $0.65 each |
70,000 | |
| Filed 2017-04-13 Tx date 2017-04-13 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+10,000 vol $0.65 each |
65,500 | |
| Filed 2017-04-13 Tx date 2017-04-13 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,575
+5,500 vol $0.65 each |
55,500 | |
| Filed 2017-04-07 Tx date 2017-04-07 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,300
+5,000 vol $0.66 each |
50,000 | |
| Filed 2017-04-06 Tx date 2017-04-06 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,750
+25,000 vol $0.67 each |
45,000 | |
| Filed 2017-04-04 Tx date 2017-03-29 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,600
+20,000 vol $0.68 each |
20,000 | |
| Filed 2017-04-04 Tx date 2017-03-27 |
$TBP
Tetra Bio-Pharma Inc. |
miller, edward
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|